These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 28782106)

  • 1. Sirolimus as treatment for 19 patients with refractory cervicofacial lymphatic malformation.
    Strychowsky JE; Rahbar R; O'Hare MJ; Irace AL; Padua H; Trenor CC
    Laryngoscope; 2018 Jan; 128(1):269-276. PubMed ID: 28782106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Sirolimus: An Option in the Management of Neonates with Life-Threatening Upper Airway Lymphatic Malformations.
    Triana P; Miguel M; Díaz M; Cabrera M; López Gutiérrez JC
    Lymphat Res Biol; 2019 Oct; 17(5):504-511. PubMed ID: 30985248
    [No Abstract]   [Full Text] [Related]  

  • 3. Intermittent Administration Regimen of Sirolimus for Refractory Cervicofacial Lymphatic Malformation.
    Gao Q; Chen H; Sun B; Cui J; Shen W
    J Craniofac Surg; 2022 May; 33(3):850-854. PubMed ID: 34538791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus for Pediatric Cervicofacial Lymphatic Malformation: A Systematic Review and Meta-Analysis.
    Kamhieh Y; Mitra R; Burnett T; Jones H; Roblin G; Hall A
    Laryngoscope; 2024 May; 134(5):2038-2047. PubMed ID: 37812168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of cervicofacial lymphatic malformations requires a multidisciplinary approach.
    Zobel MJ; Nowicki D; Gomez G; Lee J; Howell L; Miller J; Zeinati C; Anselmo DM
    J Pediatr Surg; 2021 May; 56(5):1062-1067. PubMed ID: 33982660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus-induced pulmonary hemorrhage of an infant with massive cervicofacial lymphatic malformation: A case report.
    Arya P; Prickett KK; Raol N; Briones M; Evans S
    Int J Pediatr Otorhinolaryngol; 2023 Jan; 164():111404. PubMed ID: 36469963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations.
    Yang Y; Sun M; Ma Q; Cheng X; Ao J; Tian L; Wang L; Lei D
    J Vasc Surg; 2011 Jan; 53(1):150-5. PubMed ID: 20843632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous treatment of lymphatic malformations.
    Shiels WE; Kang DR; Murakami JW; Hogan MJ; Wiet GJ
    Otolaryngol Head Neck Surg; 2009 Aug; 141(2):219-24. PubMed ID: 19643255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.
    Ozeki M; Nozawa A; Yasue S; Endo S; Asada R; Hashimoto H; Fukao T
    Orphanet J Rare Dis; 2019 Jun; 14(1):141. PubMed ID: 31196128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Airway response to sirolimus therapy for the treatment of complex pediatric lymphatic malformations.
    Alemi AS; Rosbe KW; Chan DK; Meyer AK
    Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2466-9. PubMed ID: 26549380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of radiofrequency ablation for intraoral microcystic lymphatic malformation.
    Kim SW; Kavanagh K; Orbach DB; Alomari AI; Mulliken JB; Rahbar R
    Arch Otolaryngol Head Neck Surg; 2011 Dec; 137(12):1247-50. PubMed ID: 22183906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus in the Treatment of Microcystic Lymphatic Malformations: A Systematic Review.
    Teng JMC; Hammill A; Martini J; Treat J
    Lymphat Res Biol; 2023 Apr; 21(2):101-110. PubMed ID: 35852876
    [No Abstract]   [Full Text] [Related]  

  • 13. Sirolimus in the Treatment of Vascular Anomalies.
    Triana P; Dore M; Cerezo VN; Cervantes M; Sánchez AV; Ferrero MM; González MD; Lopez-Gutierrez JC
    Eur J Pediatr Surg; 2017 Feb; 27(1):86-90. PubMed ID: 27723921
    [No Abstract]   [Full Text] [Related]  

  • 14. Surgical excision is the treatment of choice for cervical lymphatic malformations with mediastinal expansion.
    Ghaffarpour N; Burgos CM; Wester T
    J Pediatr Surg; 2018 Sep; 53(9):1820-1824. PubMed ID: 29173777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anatomic distribution of cervicofacial lymphatic malformations based on lymph node groups.
    Sjogren PP; Arnold RW; Skirko JR; Grimmer JF
    Int J Pediatr Otorhinolaryngol; 2017 Jun; 97():72-75. PubMed ID: 28483255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of bleomycin sclerotherapy for microcystic lymphatic malformation.
    Chaudry G; Guevara CJ; Rialon KL; Kerr C; Mulliken JB; Greene AK; Fishman SJ; Boyer D; Alomari AI
    Cardiovasc Intervent Radiol; 2014 Dec; 37(6):1476-81. PubMed ID: 24938907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI for Response Assessment of Extensive Lymphatic Malformations in Children Treated With Sirolimus.
    Durand R; Reid JR; Belasco JB; Shellikeri S; Calle-Toro JS; Cahill AM; Srinivasan A
    AJR Am J Roentgenol; 2021 Sep; 217(3):741-752. PubMed ID: 33405944
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-Term Follow-Up of Lymphatic Malformations in Children Treated with Sildenafil.
    Tu JH; Tafoya E; Jeng M; Teng JM
    Pediatr Dermatol; 2017 Sep; 34(5):559-565. PubMed ID: 28884903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case report of sirolimus use in early fetal management of lymphatic malformation.
    Seront E; Biard JM; Van Damme A; Revencu N; Lengelé B; Schmitz S; de Toeuf C; Clapuyt P; Veyckemans F; Prégardien C; Vikkula M; Bernard P; Boon LM
    Nat Cardiovasc Res; 2023 Jun; 2(6):595-599. PubMed ID: 39195878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Initial Sirolimus Therapy for 27 Patients with Intractable Lymphatic Malformations.
    Zhang X; Wang S; Guo Y; Liu Y; Zhang J; Li Y; Liu Q; Liu Z; Sun N; Li X; Liu Y; Du J; Cheng X; Wang X; Tai J; Ni X
    Laryngoscope; 2021 Aug; 131(8):1902-1908. PubMed ID: 33571378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.